It’s Time to Build in Healthcare

Episode Summary

Executive Summary: The episode argues that technologists should build in healthcare not just to cure disease, but to fix healthcare’s broken consumer experience, logistics, and behavior-change gaps. Vijay Pande and Daisy Wolf say the opportunity is huge because U.S. healthcare is expensive, fragmented, and under-tech-enabled, while AI, wearables, and consumer expectations now make a consumer-first, data-driven healthcare system newly feasible.

Main Topics: Why technologists belong in healthcare (Priority: 5/5): The guests argue healthcare is fundamentally a logistics, data, operations, and consumer-engagement problem—areas where technologists excel—and that regulation is a feature of big markets, not a barrier to avoid. Redefining “consumer health” beyond direct-to-consumer startups (Priority: 5/5): They broaden consumer health to include B2B distribution, insurance-covered products, and pure software, as long as the experience is consumer-grade and behavior-changing. Why now: shifting incentives and consumer demand (Priority: 5/5): The conversation identifies a new wave of consumer curiosity, especially post-COVID, plus employer-based insurance churn and high-deductible plans as forces that are creating room for consumer-driven healthcare products. Future healthcare stack: wearables, AI, and home-based care (Priority: 4/5): They envision a future where continuous monitoring, AI doctors, at-home diagnostics, and home medication delivery shift most care out of traditional clinical settings and into the home/phone. Paths to building the biggest healthcare company (Priority: 4/5): They outline three plausible models: vertical integration (payvider/full stack), horizontal marketplace (Amazon of healthcare), or infrastructure layer (Visa of healthcare payments). Why incumbents and big tech may struggle (Priority: 4/5): They argue large incumbents often optimize for payers instead of patients and that big tech’s healthcare efforts are likely to remain experiments because of the innovator’s dilemma and the need for healthcare-native expertise. AI as both a healthcare tool and healthcare’s enabler (Priority: 5/5): AI is presented as a key accelerant because it can replace expensive human services, improve triage and support, and exploit healthcare’s massive data and cost base to deliver better margins and outcomes.

Key Arguments: Healthcare is too large and too broken for medicine alone to fix; better consumer experience and behavior change are necessary to improve outcomes. Technologists are well-suited to healthcare because it is an operations, data, and logistics problem, not only a clinical problem. Regulation should be viewed as a sign of market significance; many successful companies were built in regulated environments. Consumer health should include insurance-covered, B2B-distributed, and pure software products if they improve the user experience. The current system fails patients because providers optimize for insurers, not consumers, which suppresses engagement, adherence, and preventive care. COVID catalyzed a consumer shift toward health ownership, wearables, and real-time data about one’s body. AI can leapfrog traditional software in healthcare by automating human-heavy workflows such as scheduling, prior authorization, call centers, and basic support. The most likely winning companies will either own the full stack, become the default healthcare marketplace, or build core payment infrastructure. Big tech and incumbents have the assets to experiment, but their incentives and legacy structures make deep transformation difficult. Healthcare-native technologists—people who know both software and the medical system—are increasingly available and are the best candidates to build these products.

Data Points: Medications prescribed but never taken: 50% - Used to illustrate poor adherence and the need for better consumer engagement in healthcare. Americans who are metabolically unhealthy: 88% - Cited as evidence of widespread behavior and health-system failure. U.S. healthcare share of GDP: 20% - Shows the size and economic importance of the healthcare market. Relative U.S. healthcare spend: ~2x other developed countries - Compared with peers to show inefficiency. Life expectancy gain if all cancer were cured: 3 years - Used to argue that medicine alone cannot solve Americans’ health gap. Largest public software companies that are healthcare/life science companies: 1 of 100 - Cited to highlight how underbuilt healthcare software remains. Average time Americans stay in a job / health plan churn proxy: 2.5 years - Used to explain why employer-based insurance weakens preventive-care incentives. Engagement on the referenced article post: 3,000+ likes; 250+ comments - Evidence that the thesis resonated and was controversial. A16Z claim about healthcare market size: U.S. healthcare is 5x the global advertising industry - Used to compare healthcare’s opportunity to the revenue base of major tech companies. UnitedHealth Group NPS: 4 - Example of a massive healthcare business with poor consumer experience. Healthcare delivery future estimate: 90% of care delivered by phone/home - Projected future state described by the guests. Health care industry size in America: $4 trillion - Used to justify AI and tech investment opportunities. Share of AI dollars going to healthcare: 20% - Cited as evidence of investor interest in healthcare AI.

Pivotal Quotes: "If you cure all cancer, you extend Americans' lifespan by three years." — Vijay Pande: Explains why solving disease alone is insufficient to fix population health. "The best consumer talent in the world work in technology." — Daisy Wolf: Supports the case for importing tech talent into healthcare to create better consumer experiences. "AI needs health care." — Vijay Pande: Argues healthcare’s data richness and high cost make it an ideal application for AI investment.

Implications: The episode suggests healthcare’s next wave will be built by technologists who combine software, clinical understanding, and consumer design. Expect more AI tools, wearables, home-based care, and businesses that compete on experience, not just access.